<h2 id="what-is-midazolam">What is Midazolam?</h2>
<ul>
  <li>A benzodiazepine often used as a co-induction agent to provide amnestic and anxiolytic properties.</li>
  <li>Can also be used during maintenance for anxiolytic properties. 
    <img src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQCR8Jri9tdxkf-s_8uH1MyvMUFY41OrtadB5DNvEUS1A&amp;s" alt="midazolam | 160" /></li>
</ul>
<h2 id="mechanism-of-action--pharmacokinetics-">Mechanism of Action &amp; Pharmacokinetics <sup id="fnref:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li>Facilitates the inhibitory actions of the neurotransmitter GABA by increasing the frequency of chloride channel opening.</li>
  <li>Acts on glycine receptors to produce a muscle-relaxing effect.</li>
  <li>Has few systemic effects.</li>
</ul>
<table>
  <tbody>
    <tr>
      <td>![midazolam mechanism</td>
      <td>200](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20161221073529645-0126:9780511781933:89666fig29_1.gif?pub-status=live)</td>
    </tr>
  </tbody>
</table>
<h2 id="pharmacodynamics--">Pharmacodynamics <sup id="fnref:1:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup> <sup id="fnref:2:1" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<h4 id="cardiovascular">Cardiovascular</h4>
<ul>
  <li>Minimally impacts blood pressure by reducing it through reduction of cardiac output and peripheral vascular resistance.</li>
  <li>Can have slight increase in heart rate.
    <h4 id="respiratory">Respiratory</h4>
  </li>
  <li>When co-administered with respiratory depressants or administered intravenously, apnea or severe respiratory depression can occur.
    <h4 id="central-nervous-system">Central Nervous System</h4>
  </li>
  <li>Decreases cerebral metabolic rate</li>
  <li>Decreases cerebral blood flow</li>
  <li>Has anticonvulsant properties</li>
</ul>
<h2 id="indications-">Indications <sup id="fnref:1:2" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<h4 id="anesthetic-indications">Anesthetic Indications</h4>
<ul>
  <li>Co-induction agent for general anesthesia</li>
  <li>Used for anxiolysis</li>
</ul>
<h4 id="other-indications">Other Indications</h4>
<ul>
  <li>Treatment of seizure disorders</li>
  <li>Treatment of alcohol withdrawal</li>
  <li>Treat seizures secondary to local anesthetic toxicity</li>
</ul>
<h2 id="dosage-">Dosage <sup id="fnref:1:3" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li>0.01 - 0.1 mg/kg IV for sedation purposes</li>
  <li>0.02 - 0.04 mg/kg for co-indcution purpases</li>
  <li>Onset of action within 1 - 2 minutes</li>
  <li>Half-life of elimination = 1.5 - 2.5 hours 
    <img src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcT3wutkhlNvR6Oq0CNU2AdVcTqPhJAybLCFb2LlLv7kzg&amp;s" alt="midaz bottle | 100" /></li>
</ul>
<h2 id="complications--">Complications <sup id="fnref:1:4" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup> <sup id="fnref:2:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li>Can cause anterograde amnesia, drowsiness, ataxia, falls and confusion in elderly patients so should be used cautiously</li>
  <li>Hypotension and tachycardia if administered rapidly</li>
  <li>QT prolongation, however this is a rare adverse effect</li>
  <li>Midazolam infusion syndrome is a rate side effect that may require ventilator support</li>
  <li>When administered in pregnant patients in their third trimester, it may cause neonatal withdrawal from benzodiazepines</li>
</ul>
<h2 id="references">References</h2>
<div class="footnotes" role="doc-endnotes">
  <ol>
    <li id="fn:1" role="doc-endnote">
      <p>Sullivan, P. (2012). <em>Ottawa Anesthesia Primer.</em> Echo Book Publishing <a href="#fnref:1" class="reversefootnote" role="doc-backlink">&#8617;</a> <a href="#fnref:1:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a> <a href="#fnref:1:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a> <a href="#fnref:1:3" class="reversefootnote" role="doc-backlink">&#8617;<sup>4</sup></a> <a href="#fnref:1:4" class="reversefootnote" role="doc-backlink">&#8617;<sup>5</sup></a></p>
    </li>
    <li id="fn:2" role="doc-endnote">
      <p><a href="https://www.ncbi.nlm.nih.gov/books/NBK537321/#:~:text=Midazolam%20can%20be%20used%20for,greater%20patient%20and%20clinician%20acceptance.">Lingamchetty, T.N., Hosseini, S.A., Saadabadi, A. (2023). Midazolam. <em>StatPearls</em>.</a> <a href="#fnref:2" class="reversefootnote" role="doc-backlink">&#8617;</a> <a href="#fnref:2:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a> <a href="#fnref:2:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a></p>
    </li>
  </ol>
</div>